Prof. N.Meyer (MD, PhD) is an onco-dermatologist. He works as the head of skin cancers unit of the Toulouse University Cancer Institute, and conducts research on characterization of melanoma biomarkers, and tumor immune escape. He participated as an investigator in more than 30 clinical trials on skin cancers and currently leads 2 early clinical trials on immune-checkpoints inhibition for the treatment of melanoma or skin epidermoid carcinoma. He is particularly interested in research on the role of TNFa in melanoma immune escape and is the PI and coordonattor of a Phase I clinical trial of TNFa inhibitors as immune checkpoint inhibitor for the treatment of melanoma.
Prof. N. Meyer is member of the Toulouse cancer research center (namely CRCT - Centre de Recherche en Cancérologie de Toulouse).